论文部分内容阅读
1996-05～1998-05我们采用小儿乙肝颗粒治疗小儿乙肝30例,并与抗乙肝核糖核酸合用大剂量“乙肝疫苗”组对照,观察其细胞免疫及体液免疫指标,探讨小儿乙肝颗粒的作用机理,现将结果报道如下。1 临床资料 治疗组:男18例,女12例,平均年龄7.73±2.49,平均病程2.67±0.90。对照组:男19例,女11例,平均年龄7.01±3.49,平均病程2.48±1.32。 经统计学处理两组患儿在年龄、性别、病程等方面无显著性差异(P>0.05)。2 治疗方法 治疗组:口服小儿乙肝颗粒(黄芪、太子参、苍白术、柴胡、虎杖、胡黄连、丹参等),湖北中医学院附属医院制剂室提
1996-05 ~ 1998-05 We used pediatric hepatitis B particles in children with hepatitis B in 30 cases, and combined with anti-hepatitis B virus RNA combined with high-dose “hepatitis B vaccine” group control, observation of cellular immunity and humoral immunity indicators, to explore the mechanism of pediatric hepatitis B particles The results are reported below. 1 clinical data treatment group: 18 males and 12 females, mean age 7.73 ± 2.49, the average duration of 2.67 ± 0.90. Control group: 19 males and 11 females, the average age 7.01 ± 3.49, the average duration of 2.48 ± 1.32. There was no significant difference in age, sex, disease duration between the two groups by statistical analysis (P> 0.05). 2 treatment of treatment group: oral administration of hepatitis B particles (Astragalus, heterophylla, pale surgery, Bupleurum, Polygonum cuspidatum, rhubarb, Salvia, etc.), Hubei University of Traditional Chinese Medicine Hospital,